APA

Terryn W., Vanholder R., Hemelsoet D., Leroy B. P., Van Biesen W., De Schoenmakere G., Wuyts B., Claes K., De Backer J., De Paepe G., Fogo A., Praet M. & Poppe B. (20130225). Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERT. : JIMD reports.

Chicago

Terryn W, Vanholder R, Hemelsoet D, Leroy B P, Van Biesen W, De Schoenmakere G, Wuyts B, Claes K, De Backer J, De Paepe G, Fogo A, Praet M and Poppe B. 20130225. Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERT. : JIMD reports.

Harvard

Terryn W., Vanholder R., Hemelsoet D., Leroy B. P., Van Biesen W., De Schoenmakere G., Wuyts B., Claes K., De Backer J., De Paepe G., Fogo A., Praet M. and Poppe B. (20130225). Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERT. : JIMD reports.

MLA

Terryn W, Vanholder R, Hemelsoet D, Leroy B P, Van Biesen W, De Schoenmakere G, Wuyts B, Claes K, De Backer J, De Paepe G, Fogo A, Praet M and Poppe B. Questioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERT. : JIMD reports. 20130225.